Regulatory oversight on the use of experimental therapies during a pandemic: The case of early access to convalescent plasma therapy in three LMICs

Clinicians, especially in low- and middle-income countries (LMICs), contend with limited economic and healthcare resources in deciding appropriate and feasible care for their patients. Some of the LMICs affected by COVID-19 implemented convalescent plasma therapy without sufficient regulatory guidan...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernabe, Rosemarie, Torres, Cristina, Wangge, Grace, Jimenez, Edlyn, Karbwang, Juntra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664719/
https://www.ncbi.nlm.nih.gov/pubmed/34906688
http://dx.doi.org/10.1016/j.drudis.2021.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664719/
https://www.ncbi.nlm.nih.gov/pubmed/34906688
http://dx.doi.org/10.1016/j.drudis.2021.12.002

Ejemplares similares